Article Information
vol. 7 no. 282 282cm2
- .
Author Information
- Hans-Dieter Volk1,2,*,
- Molly M. Stevens3,4,5,
- David J. Mooney6,
- David W. Grainger7 and
- Georg N. Duda1,8
- 1Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité–Universitätsmedizin Berlin, Germany.
- 2Institute for Medical Immunology, Charité–Universitätsmedizin Berlin, Germany.
- 3Department of Materials, Imperial College London, London SW7 2AZ, UK.
- 4Department of Bioengineering, Imperial College London, London SW7 2AZ, UK.
- 5Institute for Biomedical Engineering, Imperial College London, London SW7 2AZ, UK.
- 6Wyss Institute and Harvard School of Engineering and Applied Sciences, Cambridge, MA 02138, USA.
- 7Department of Pharmaceutics and Pharmaceutical Chemistry, and Department of Bioengineering, University of Utah, Salt Lake City, UT 84112, USA.
- 8Julius Wolff Institute, Charité–Universitätsmedizin Berlin, Germany.
- ↵*Corresponding author. E-mail: hans-dieter.volk{at}charite.de